Pilot testing a patient decision aid as a strategy to reduce overtreatment for older women with early-stage breast cancer.
Am J Surg
; 235: 115774, 2024 Sep.
Article
en En
| MEDLINE
| ID: mdl-38834420
ABSTRACT
BACKGROUND:
Despite national guidelines recommending omission of sentinel lymph node biopsy (SLNB) and post-lumpectomy radiotherapy (RT) in older women with early-stage, hormone receptor-positive (HR+) breast cancer, these practices persist. This pilot study assesses whether a decision aid can target patient-level determinants of low-value treatments.METHODS:
We adapted and pilot-tested a decision aid in women ≥70 years old with early-stage HR â+ âbreast cancer. Primary outcomes included acceptability and appropriateness of the decision aid. Secondary outcomes included treatment choice and satisfaction with decision.RESULTS:
Twenty-three patients enrolled in the trial. 19 completed survey one; 16 completed survey two. Primary outcomes demonstrated that 84% of patients agreed or strongly agreed the aid was acceptable and appropriate. Secondary outcomes demonstrated that 19% of patients underwent SLNB (below pre-intervention baseline), and 85% received adjuvant RT (change not statistically significant).CONCLUSIONS:
We demonstrate that a decision aid may effectively target patient-level factors contributing to overuse of low-value therapies.Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Neoplasias de la Mama
/
Técnicas de Apoyo para la Decisión
/
Biopsia del Ganglio Linfático Centinela
/
Sobretratamiento
Límite:
Aged
/
Aged80
/
Female
/
Humans
Idioma:
En
Revista:
Am J Surg
/
Am. j. surg
/
American journal of surgery
Año:
2024
Tipo del documento:
Article